Risk factors for early postoperative recurrence in single and small hepatitis B virus-associated primary hepatocellular carcinoma
- PMID: 33044114
- PMCID: PMC7556173
- DOI: 10.1177/0300060520961260
Risk factors for early postoperative recurrence in single and small hepatitis B virus-associated primary hepatocellular carcinoma
Abstract
Objective: To investigate the risk factors of early postoperative recurrence in patients with single and small (≤3 cm) hepatitis B virus-associated primary hepatocellular carcinoma (HBV-HCC).
Methods: This retrospective study analyzed patients with single and small HBV-HCC. All patients were followed up for 1 year after surgery.
Results: Among 182 patients, 54 patients had early recurrence within 1 year. The recurrence group had higher proportions of men, drinking history, Child-Turcotte-Pugh (CTP) class C, patients who underwent transarterial chemoembolization (TACE), and serum alpha-fetoprotein (AFP) >10 ng/mL as well as higher gamma-glutamyl transpeptidase (GGT) levels and lower total protein (TP) and CD8+ T lymphocyte levels than the no recurrence group. Cox multivariate regression analysis demonstrated that drinking history (HR, 1.312; 95% CI, 1.042-1.652), CTP class C (HR, 1.236; 95% CI, 1.037-1.473), TACE treatment (HR, 1.241; 95% CI, 1.026-1.501), GGT (HR, 1.138; 95% CI, 1.042-1.243), TP (HR, 0.729; 95% CI, 0.555-0.957), and AFP (HR, 2.519; 95% CI, 1.343-4.726) were independently associated with early postoperative recurrence.
Conclusion: Drinking history, CTP class C, TACE, serum AFP, GGT, and TP levels were independently associated with early postoperative recurrence in patients with single and small HBV-HCC.
Keywords: Child–Turcotte–Pugh; Hepatitis B virus; alpha-fetoprotein; drinking history; gamma-glutamyl transpeptidase; primary hepatocellular carcinoma; prognosis; recurrence; total protein; transarterial chemoembolization.
Figures


Similar articles
-
Preoperative platelet-albumin-bilirubin grades predict the prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after liver resection: A retrospective study.Medicine (Baltimore). 2018 Mar;97(12):e0226. doi: 10.1097/MD.0000000000010226. Medicine (Baltimore). 2018. PMID: 29561452 Free PMC article.
-
Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.World J Surg Oncol. 2016 Apr 2;14:100. doi: 10.1186/s12957-016-0855-z. World J Surg Oncol. 2016. PMID: 27038790 Free PMC article.
-
Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization.Cytokine. 2015 Dec;76(2):449-457. doi: 10.1016/j.cyto.2015.07.001. Epub 2015 Jul 8. Cytokine. 2015. PMID: 26163999
-
Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.World J Gastroenterol. 2015 Jul 21;21(27):8249-55. doi: 10.3748/wjg.v21.i27.8249. World J Gastroenterol. 2015. PMID: 26217076 Free PMC article. Review.
-
Risk factors of secondary infection/recurrence after ablation for liver cancers: A systemic review and meta-analysis.J Cancer Res Ther. 2022 Sep;18(5):1352-1359. doi: 10.4103/jcrt.jcrt_291_21. J Cancer Res Ther. 2022. PMID: 36204883
Cited by
-
Predictive models and early postoperative recurrence evaluation for hepatocellular carcinoma based on gadoxetic acid-enhanced MR imaging.Insights Imaging. 2023 Jan 8;14(1):4. doi: 10.1186/s13244-022-01359-5. Insights Imaging. 2023. PMID: 36617581 Free PMC article.
-
Hepatitis B core-related antigen as a predictive biomarker for recurrence in primary hepatocellular carcinoma: A meta-analysis.World J Gastrointest Oncol. 2025 May 15;17(5):105148. doi: 10.4251/wjgo.v17.i5.105148. World J Gastrointest Oncol. 2025. PMID: 40487961 Free PMC article.
-
Recent advances in recurrent hepatocellular carcinoma therapy.World J Hepatol. 2023 Apr 27;15(4):460-476. doi: 10.4254/wjh.v15.i4.460. World J Hepatol. 2023. PMID: 37206651 Free PMC article. Review.
References
-
- Zhou HY, Luo Y, Chen WD, et al. Hepatitis B virus mutation may play a role in hepatocellular carcinoma recurrence: a systematic review and meta-regression analysis. J Gastroenterol Hepatol 2015; 30: 977–983. - PubMed
-
- Miller ZA, Lee KS. Screening for hepatocellular carcinoma in high-risk populations. Clin Imaging 2016; 40: 311–314. - PubMed
-
- Singal AG, Mittal S, Yerokun OA, et al. Hepatocellular carcinoma screening associated with early tumor detection and improved survival among patients with cirrhosis in the US. Am J Med 2017; 130: 1099–1106.e1. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous